Table 3.

Prevalence of adiposity- [25] and dysglycemia- [26] based chronic disease in a Czech population *.

Adiposity-Based Chronic Disease (ABCD)	Total (%)	Male (%)	Female (%)
No ABCD	37.2	33.2	40.6
Stage 0 ABCD (metabolically healthy)	2.3	4.0	0.9
Stage 1 ABCD (mild related complications)	31.4	28.4	33.9
Stage 2 ABCD (moderate–severe-related complications)	29.1	34.4	24.7
Total ABCD (abnormal adiposity)	62.8	66.8	59.4
Dysglycemia-Based Chronic Disease (DBCD)	Total (%)	Male (%)	Female (%)
No DBCD	30.6	30.9	30.3
Stage 1 DBCD (insulin resistance)	54.2	48.5	59.0
Stage 2 DBCD (prediabetes)	10.3	13.8	7.5
Stage 3 DBCD (type 2 diabetes)	3.7	4.9	2.6
Stage 4 DBCD (Type 2 diabetes and vascular complications)	1.2	1.9	0.6
Total DBCD (dysglycemia)	69.4	69.1	69.7

* In this study, only abnormal amounts of adiposity and distribution are detected (not function) for ABCD designation. Abbreviations: ABCD—adiposity-based chronic disease, CVD—cardiovascular disease, DBCD—dysglycemia-based chronic disease.